RCT | Operative vs. nonoperative treatment of acute unstable chest wall injuries.
Operative vs Nonoperative Treatment of Acute Unstable Chest Wall Injuries: A Randomized Clinical Trial – JAMA Surgery (free for a limited period) Invited commentary: Operative Treatment of Acute Unstable Chest Wall Injuries—Let Us All Take a Deep Breath – JAMA Surgery (free for a limited period) Author Interview: Operative vs Nonoperative Treatment of Acute Unstable […]
The post RCT | Operative vs. nonoperative treatment of acute unstable chest wall injuries. appeared first on Links Medicus.
Long covid—an update for primary care.
Long covid—an update for primary care – The BMJ
The post Long covid—an update for primary care. appeared first on Links Medicus.
Series | Sleep and sleep disorders.
Homepage: Sleep and sleep disorders (free registration required for all articles) Editorial: Waking up to the importance of sleep Series: Understanding and approaching excessive daytime sleepiness Insomnia Circadian rhythms and disorders of the timing of sleep Sleep function: an evolutionary perspective Commentaries: How and why do human beings sleep? Social determinants and health disparities affecting […]
The post Series | Sleep and sleep disorders. appeared first on Links Medicus.
M-A | Optimal management, prevalence, and clinical behavior of saddle pulmonary embolism.
Optimal management, prevalence, and clinical behavior of saddle pulmonary embolism: A systematic review and meta-analysis – Thrombosis Research Commentary on Twitter #review Despite its ominous radiologic appearance, clinical behavior and mortality from #saddle pulmonary embolism are comparable to other pulmonary embolism types. https://t.co/NpLs77f5MT pic.twitter.com/2uZ4jhY32G — Thrombosis Research (@ThrombosisRese1) September 5, 2022
The post M-A | Optimal management, prevalence, and clinical behavior of saddle pulmonary embolism. appeared first on Links Medicus.
M-A | Combination therapy with long-acting bronchodilators and risk of adverse cardiovascular events in patients with COPD.
Combination therapy with long-acting bronchodilators and the risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis – European Respiratory Journal (link to abstract – $ for full-text)
The post M-A | Combination therapy with long-acting bronchodilators and risk of adverse cardiovascular events in patients with COPD. appeared first on Links Medicus.
RCT | High-flow nasal cannula oxygen did not reduce mortality in patients with respiratory failure due to COVID-19.
Effect of High-Flow Nasal Cannula Oxygen vs Standard Oxygen Therapy on Mortality in Patients With Respiratory Failure Due to COVID-19: The SOHO-COVID Randomized Clinical Trial – JAMA (link to abstract – $ for full-text) Commentary: High-Flow Oxygen Fails to Reduce Mortality due to COVID-19 Respiratory Failure – HCP Live
The post RCT | High-flow nasal cannula oxygen did not reduce mortality in patients with respiratory failure due to COVID-19. appeared first on Links Medicus.
M-A of randomized trials | High-flow nasal cannula oxygen therapy vs. non-invasive ventilation for patients with acute exacerbation of COPD after extubation.
High-Flow Nasal Cannula Oxygen Therapy versus Non-Invasive Ventilation for AECOPD Patients After Extubation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials – International Journal of Chronic Obstructive Pulmonary Disease
The post M-A of randomized trials | High-flow nasal cannula oxygen therapy vs. non-invasive ventilation for patients with acute exacerbation of COPD after extubation. appeared first on Links Medicus.
RCT | Dipeptidyl peptidase-1 inhibition does not improve outcomes in patients hospitalized with COVID-19.
Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial – The Lancet Respiratory Medicine Commentary on Twitter NEW Research—Brensocatib treatment did not improve clinical status at day 29 in patients hospitalised with #COVID19 Being presented at #ERSCongress, ALERT 3 session, Sept 5 from 13:15 BST From @profjdchalmers, @keirholly, […]
The post RCT | Dipeptidyl peptidase-1 inhibition does not improve outcomes in patients hospitalized with COVID-19. appeared first on Links Medicus.
RCT | Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19.
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial – The Lancet Respiratory Medicine Commentaries on Twitter Interesting results in the #PANAMO trial of vilobelimab, an anti-C5a antibody, in critically ill ICU patients w/ COVID19. People on MV (n=386) randomized to […]
The post RCT | Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19. appeared first on Links Medicus.
RCT | A double-dose influenza vaccination during hospitalization for acute coronary syndrome did not improve outcomes compared to standard-dose outpatient vaccination.
Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial – European Heart Journal Commentary on Twitter In the VIP-ACS trial, among patients hospitalised with an ACS, double dose influenza vaccination before discharge does not reduce cardiovascular and pulmonary outcomes compared with standard dose vaccination ?https://t.co/L9e7MXWfWV#EHJ #ESCCongress @ehj_ed @rladeiraslopes pic.twitter.com/95o50krrwm — European Society of […]
The post RCT | A double-dose influenza vaccination during hospitalization for acute coronary syndrome did not improve outcomes compared to standard-dose outpatient vaccination. appeared first on Links Medicus.